elop and commercialize CicloMulsion° and NeuroSTAT° for cardio- and neuroprotection in China Beijing (China) and Lund (Sweden) - November 20, 2012. NeuroVive, the leading mitochondrial medicine company, today announces a collaboration agreement with Sihuan Pharmaceutical Holdings Group Ltd. for the develo

China with an eye to obtaining registration in the Chinese market. The news release is below and attached. Regards, Steve Campbell NEWS RELEASE NeuroVive and Sihuan Pharmaceutical to develop and commercialize CicloMulsion° and NeuroSTAT° for cardio- and neuroprotection in China Beijing (China) and Lu